CytoDyn Announces Investment Community Conference Call for October 19, 2017

VANCOUVER, Washington, Oct. 17, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that management will hold an investment community conference call on Thursday, October 19, 2017, at 1:00 p.m. PT / 4:00 p.m. ET to discuss the Company’s recent meeting with the FDA and other clinical trial and regulatory developments.

Conference Call and Webcast Instructions
Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).

A live audio webcast may also be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 60 days.  Web participants are encouraged to go to the website 15 minutes prior to the start of the call to register, download and install any necessary software.  The webcast can also be accessed via the following link:  http://cytodyn.equisolvewebcast.com/10-19-17.

A replay of the conference call will be available until December 19, 2017.  To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international); Conference ID: 13672522.

CONTACTS:
Investors:
LHA Investor Relations
Jody Cain
Phone: 310-691-7100
E-mail: [email protected]

Media:
Joan E. Kureczka
Bioscribe, Inc.
Phone: 415-821-2413
Email: [email protected]